Check out this: Kintara Therapeutics Inc (KTRA) could be on the verge of a big rally

Kintara Therapeutics Inc (NASDAQ: KTRA) is -26.59% lower on its value in year-to-date trading and has touched a low of $0.11 and a high of $6.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KTRA stock was last observed hovering at around $0.12 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $0.12, the stock is -4.45% and -31.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.16 million and changing 2.05% at the moment leaves the stock -95.17% off its SMA200. KTRA registered -98.06% loss for a year compared to 6-month loss of -96.75%. The firm has a 200-day simple moving average (SMA200) of -$0.83.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -15.25% gain in the last 1 month and extending the period to 3 months gives it a -70.14%, and is -0.32% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.65% over the week and 11.91% over the month.

Distance from 52-week low is 12.16% and -98.12% from its 52-week high.

Kintara Therapeutics Inc quarterly earnings per share for the current quarter are estimated at $0.

Kintara Therapeutics Inc (KTRA) Top Institutional Holders

11 institutions hold shares in Kintara Therapeutics Inc (KTRA), with institutional investors hold 2.79% of the company’s shares. The shares outstanding are 3.39M, and float is at 3.31M with Short Float at 4.96%. Institutions hold 2.72% of the Float.

The top institutional shareholder in the company is Geode Capital Management, LLC with over 14036.0 shares valued at $56565.0. The investor’s holdings represent 0.80% of the KTRA Shares outstanding. As of Jun 29, 2023, the second largest holder is State Street Corporation with 10721.0 shares valued at $43205.0 to account for 0.61% of the shares outstanding. The other top investors are Acadian Asset Management. LLC which holds 6480.0 shares representing 0.37% and valued at over $26114.0, while Tower Research Capital LLC (TRC) holds 0.27% of the shares totaling 4777.0 with a market value of $19251.0.

Kintara Therapeutics Inc (KTRA) Insider Activity

A total of 0 insider transactions have happened at Kintara Therapeutics Inc (KTRA) in the last six months, with sales accounting for 0 and purchases happening 0 times.